We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Gyre Therapeutics
GYRE
$629M
| $537K | 0.01% |
16,650
+2,927
| +21% | +$115K |
|
|
CMLS
777
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $536K | 0.01% |
99,850
+45,020
| +82% | +$211K |
|
778
MeiraGTx Holdings
MGTX
$1.08B
| $535K | 0.01% |
40,394
+20,337
| +101% | +$268K |
|
|
ASRT
779
DELISTED
Assertio
ASRT
| $533K | 0.01% |
13,342
+9,321
| +232% | +$453K |
|
780
Sutro Biopharma
STRO
$386M
| $533K | 0.01% |
5,301
-972
| -15% | -$91.8K |
|
|
PTN
781
Palatin Technologies
PTN
$14.4M
| $526K | 0.01% |
890
+361
| +68% | +$243K |
|
|
CSTR
782
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $525K | 0.01% |
53,514
-7,937
| -13% | -$83.8K |
|
|
GBT
783
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $524K | 0.01% |
+9,507
| New | +$604K |
|
784
Urban Edge Properties
UE
$2.9B
| $521K | 0.01% |
53,561
| – | – |
|
785
Impinj
PI
$4.24B
| $519K | 0.01% |
19,699
-1,610
| -8% | -$42.5K |
|
786
IDEAYA Biosciences
IDYA
$3.43B
| $518K | 0.01% |
41,273
-15,644
| -27% | -$194K |
|
787
Itron
ITRI
$4.48B
| $513K | 0.01% |
+8,446
| New | +$537K |
|
|
DSSI
788
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $513K | 0.01% |
74,607
-379
| -0.5% | -$3.07K |
|
789
Cal-Maine
CALM
$4.43B
| $511K | 0.01% |
+13,319
| New | +$563K |
|
790
Carter Bankshares
CARE
$765M
| $507K | 0.01% |
76,271
-9,936
| -12% | -$70.9K |
|
791
ONE Gas
OGS
$5.01B
| $498K | 0.01% |
7,220
-14,858
| -67% | -$1.09M |
|
792
Northeast Bank
NBN
$1.04B
| $497K | 0.01% |
26,986
-30,329
| -53% | -$539K |
|
793
American Coastal Insurance
ACIC
$536M
| $496K | 0.01% |
81,884
-6,311
| -7% | -$48.4K |
|
|
SEAC
794
DELISTED
Seachange International Inc
SEAC
| $492K | 0.01% |
28,278
+4,752
| +20% | +$126K |
|
795
Everspin Technologies
MRAM
$303M
| $491K | 0.01% |
86,619
-63,734
| -42% | -$406K |
|
796
PC Connection
CNXN
$2.09B
| $487K | 0.01% |
+11,858
| New | +$519K |
|
797
Bloom Energy
BE
$48.2B
| $485K | 0.01% |
27,015
-600
| -2% | -$8.96K |
|
|
TGH
798
DELISTED
Textainer Group Holdings limited
TGH
| $484K | 0.01% |
34,154
+16,674
| +95% | +$179K |
|
|
IVC
799
DELISTED
Invacare Corporation
IVC
| $484K | 0.01% |
64,305
| – | – |
|
800
DHT Holdings
DHT
$2.99B
| $483K | 0.01% |
93,539
+77,824
| +495% | +$430K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.